Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-097487

Chief Financial Officer gave up 11,891 shares (to pay taxes)

  • Chief Financial Officer acquired 23,438 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bellemin Jean-Marc · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-03 Exercise or conversion : show line 1 in the form +23,438 41,239 D
2024-09-03 Shares withheld for taxes : show line 2 in the form −11,891 $10.85 $129,017 29,348 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-09-03 Exercise or conversion : show line 3 in the form Restricted Stock Units −23,438 23,437 D
Loading xslF345X05/tm2423453-1_4seq1.xml…